How do traditional pharmaceutical companies upgrade their listing?

In recent years, with the gradual advancement of the separation of medicine and medicine, the demand for chronic disease services in an aging society has surged, and many factors, such as price reduction in drug bidding and purchasing, and strict control of the proportion of drugs in hospitals, have brought great benefits to the development of pharmacies.

The Special Consultation Report on the Opportunities, Challenges and Coping Strategies of China Internet for Chain Pharmacy Industry shows that the scale of pharmaceutical e-commerce market in China was 4.6 billion yuan in 20 14, accounting for 1.9% of the pharmaceutical retail market. Compared with the scale of 240 billion yuan in the pharmaceutical industry, the gap is still very large. However, once the prescription drug market is liberalized, medical e-commerce will gain hundreds of billions of dollars, and online drugs will also account for 30% of the pharmaceutical retail market.

Compared with traditional medical retailers, medical e-commerce has the advantages of low construction cost, diverse platform products, low-price competition and convenient purchase. Based on the above characteristics, under the background of deepening medical reform, promoting the separation of medicine and promoting the Internet plus medicine, medical e-commerce is gradually favored by the policy. Among them, China's 20 15 "Supervision and Management Measures of the US Food and Drug Administration (Draft for Comment)" is the most typical. This document intends to liberalize the control of prescription drugs and allow online sales of prescription drugs, which is conducive to the great development of medical e-commerce in the future.